People in the News | GenomeWeb

People in the News

Jan 12, 2017

Francis Ouellette

Génome Québec has appointed Francis Ouellette as VP of scientific affairs. In this role, Ouellette will lead efforts to define the company's vision and develop its scientific strategy. He will start in his new role Feb. 27. Prior to his work with Génome Québec, Ouellette served as associate director of the informatics and biocomputing platform and lead investigator at the Ontario Institute for Cancer Research. He also served as associate professor in the department of medical genetics at the University of British Columbia, director of the UBC Bioinformatics Center at the Michael Smith Laboratories, and coordinated the GenBank database for the US National Institutes of Health.

Jan 11, 2017

Mark Adams

Jackson Laboratory has appointed Mark Adams as director of microbial genomic services. In this role, Adams will enhance the organization's large scale microbiome initiatives. Adams joins Jackson Laboratory from the J. Craig Venter Institute, where he directed programs that characterized genomic changes in antibiotic resistance. He also founded the Institute for Genomic Research, co-founded Celera Genomics, and served as associate professor of genetics at Case Western Reserve University.

Jan 09, 2017

Haywood Cochrane

Acuamark Diagnostics announced Haywood Cochrane has joined its board of directors. He will transition from his current position as a member of the firm's advisory board. Cochrane is currently a director at Corium and vice chair of the board at the University of North Carolina, Chapel Hill. Previously, he was CEO of CHD Meridian and was president and CEO of Allied Clinical Labs. 

Jan 09, 2017

Randy Scott, Sean George

Invitae President and Chief Operating Officer Sean George will take over as CEO, effective immediately, the company announced. Current CEO Randy Scott will continue full time at Invitae serving as executive chairman of the board of directors. The changes come as the company is focused on driving global growth in genetic testing. Previously, George was a co-founder and CEO of genetic analysis startup Locus Development. Scott previously served as executive chairman at Genomic Health and chief operating officer at personal genomics firm Navigenics.

Jan 06, 2017

Philip Bourne

The National Institutes of Health announced today that Philip Bourne will be leaving his post as associate director for data science effective April 30, 2017. Bourne joined the NIH in 2014 to lead the Big Data to Knowledge program. He will join the University of Virginia, Charlottesville as Stephenson Chair of data science, director of the Data Science Institute, and professor in the Department of Biomedical Engineering. 

Jan 06, 2017

Christian Henry

Ginkgo Bioworks has appointed Christian Henry to its board of directors. Henry joins from Illumina, where he served as executive VP and chief commercial officer. While at Ilumina, he also served as CFO, general manager of Life Sciences, and senior VP of corporate development. Before Illumina, he served as CFO of Tickets.com and VP of finance of Affymetrix.

Jan 06, 2017

Ian Clark

Guardant Health has appointed Ian Clark to its board of directors. Clark joins Guardant Health from Genetech, where he served as CEO, and Roche, where he led North American commercial operations. He has also held leadership roles at Novartis, Sanofi, and Ivax.

Jan 06, 2017

Troy Cox, Michael Pellini

Foundation Medicine announced that it has appointed Troy Cox as CEO to succeed Michael Pellini, who has been appointed as chairman of the board of directors. Pellini replaces Alexis Borisy, who will continue to serve on the board. Cox joins Foundation Medicine from Roche-Genetech, where he led one of the largest oncology portfolios in the US. Before joining Genentech, he held leadership positions at UCB BioPharma, Sanofi-Aventis, and Schering-Plough.

Jan 05, 2017

Stephanie Hallam

Claritas Genomics has appointed Stephanie Hallam as VP of molecular diagnostics. Hallam joins Claritas from Good Start Genetics, where she served as VP of laboratory operations and medical director.. She has also served in management and leadership positions at Genzyme Genetics, Athena Diagnostics, the University of Utah, and the University of Colorado.

Jan 05, 2017

Michael Nemzek

MedGenome has appointed Michael Nemzek as chief commercial officer. Nemzek has held executive leadership positions in both public companies and private companies, including RareCyte, Affymetrix, and Velocity11. He also holds advanced degrees in chemistry from North Carolina State University and in management from the University of Maryland.

Jan 05, 2017

Brady Davis, John Ellithorpe

DNAnexus expands its executive leadership team by appointing Brady Davis as vice president of strategy and marketing and John Ellithorpe as chief product officer. Davis comes to DNAnexus from Illumina, where he identified investment and acquisition opportunities, developed strategic partnerships, and led global product marketing for informatics. Before his work at Illumina, he led business development, strategy, and innovation for Oracle's Health Science Global Business Unit. Ellithorpe joins Illumina from Vantiq, where he served as chief product officer. Before his work at Vantiq, he co-founded Model N, where he served as chief technology officer and chief product officer.

Jan 04, 2017

Cynthia Collins

Human Longevity has appointed Cynthia Collins as CEO. She replaces Craig Venter, who will remain at the company and serve as executive chairman of the board of directors. Collins comes to HLI from GE Healthcare, where she served as CEO and general manager for Cell Therapy and Purification and ANalysis Businesses. Before that she served as CEO of GE's Clarient Diagnostics. She has also held various executive positions at Genvec, Cellular Analysis Business Group, Sequoia Pharmaceuticals, and Clinical Microsensors (now Genmark).

Jan 04, 2017

Jan Verstreken

Hologic has appointed Jan Verstreken as regional president for Europe, Middle East and Africa (EMEA), and Canada. In this role, Verstreken will build growth strategies in the EMEA and Canadian markets. He most recently served as president for Asia Pacific. Before he joined Hologic, he had an impressive career at Teleflex.

Jan 03, 2017

Garret Hampton

Illumina has hired Garret Hampton as executive vice president of clinical genomics, effective Jan. 9, 2017. Hampton will be responsible for Illumina's clinical genomics group, leading the reproductive and genetic health, oncology, and regulatory and medical affairs business units. He will also oversee CLIA labs and the chief medical officers organization. Previously, Hampton served as global head of oncology biomarker development and companion diagnostics at Genentech. He also co-led the Roche personalized medicine R&D initiative and chaired the Roche/Foundation Medicine joint R&D committee. In addition, he has held scientific and management roles at Celgene, the Genomics Institute of the Novartis Research Foundation, and the University of California, San Diego. 

Dec 21, 2016

Mark Boyle

Clinical Genomics has appointed Mark Boyle as president of in vitro diagnostics. Boyle joins Clinical Genomics from Qiagen, where he served as a VP for nearly five years. Previously, he served as president of Cellestis, prior to that firm's acquisition by Qiagen and successful integration into the company. He has also served as general manager for the UK subsidiary of Diagnostics Systems Laboratories.

Dec 21, 2016

Aarush Manchanda

Portable Genomics has appointed Aarush Manchanda to its board of directors. Manchanda is board certified in internal medicine, cardiovascular disease, nuclear cardiology, cardiac computed tomography, and echocardiography. He currently works as a staff cardiologist at Cedar City Heart Clinic in Cedar City, Utah. He also serves as medical director of Cardiovascular Services at Cedar City Hospital.

Dec 21, 2016

Jonathan Seaton

Illumina has appointed Jonathan Seaton as senior VP for corporate and business development. In this role, Seaton will be responsible for global business development activities, including strategic commercial deals, mergers and acquisitions, licensing, and partnerships. He joins Illumina from Becton Dickinson, where he was VP and head of strategy and business development for the Life Sciences segment. He previously held leadership roles at Hoffman-La Roche, Roche Tissue Diagnostics, LS9, and several consulting firms and investment banks.

Dec 20, 2016

Kelly Hunter, Ryan Hayman, Lorenzo Gutierrez, and Aaron Jordan

Kelly Hunter, Ryan Hayman, Lorenzo Gutierrez, and Aaron Jordan have joined Toronto-based start-up ChipCare Corporation, manufacturer of a point-of-care platform for cell-based, immunoassay, and molecular diagnostic testing.

Hunter, a seven-year veteran of BioFire Diagnostics where she developed real-time PCR assays, joins ChipCare as a senior assay development scientist. Hayman, also joining the firm as a senior assay development scientist, was previously assistant director of R&D at Xagenic and has expertise in multiplexed bead-based biosensors and optical detection systems.

Gutierrez has joined the firm as director of hardware engineering and has a background in device prototyping and commercialization, while Jordan will be director of project management and has previously led global projects at Thermo Fisher Scientific and Roche Diagnostics. 

Dec 15, 2016

Stephen Rusckowski

Quest Diagnostics has appointed Stephen Rusckowski as the chairman of its board of directors. Rusckowski succeeds Daniel Stanzione, who will be staying on as lead independent director. Rusckowski joined Quest in 2012 and continues to serve as president and CEO.

Dec 15, 2016

Peter Wilver

In a filing with the US Securities and Exchange Commission this week, Thermo Fisher Scientific announced that Peter Wilver will retire effective March 31, 2017. Wilver became an executive officer of the company in 2003 and is currently serving as executive vice president and chief administrative officer.

Dec 15, 2016

Hans Lehrach, Scott Parazynski, and Shamil Sunyaev

Veritas Genetics has appointed Hans Lehrach, Scott Parazynski, and Shamil Sunyaev to its scientific advisory board. Lehrach is director emeritus at the Max Planck Institute of Molecular Genetics in Germany, CEO and CSO for the Dahlem Center for Genome Research and Medical System Biology, and the founder of Alacris Theranostics. Parazynski is a former NASA astronaut and physiologists with expertise in human adaption to extreme environments. He is currently CEO of Fluidity Technologies and a product developer. Sunyaev is professor of biomedical informatics and medicine at Harvard Medical School, serves as chair in Computational Genomics and research geneticist at Brigham and Women's Hospital, and an associate member of the Broad Institute.

Dec 12, 2016

John McChesney, Tali Mackay, David Taylor, and Gregory Tsongalis

Theranos has appointed John McChesney, Tali Mackay, David Taylor, and Gregory Tsongalis to executive positions. McChesney has been named senior VP of operations. He previously served at Medtronic, Thermo Fisher Scientific, and GenapSys. Mackay has been named senior VP of corporate communications and investor relations. She previously worked at Genentech, Baxter, and various global public relations firms. Taylor has been promoted to general counsel. He joined Theranos as senior litigation counsel in May. Tsongalis has been appointed to the firm's Scientific and Medical Advisory Board. He has served on science and medical advisory boards at AltheaDx, Gentura Dx-USA, and Physicians Choice Laboratory Services. 

Dec 09, 2016

Sherry Buck

Waters has appointed Sherry Buck as senior vice president and CFO effective Jan. 9, 2017. Buck replaces Eugene Cassis, who will transition to a senior advisory role. Before coming to Waters, she served as CFO for Libbey. Prior to joining Libbey, Buck spent nearly 20 years at Whirlpool in a number of leadership roles, including CFO, global product and enterprise cost leadership, and vice president of US finance.

Dec 08, 2016

Don Hardison

IQuity has appointed Don Hardison to its board of directors. Hardison joins IQuity from Good Start Genetics where he served as president, CEO, and board member. He has previously held a number of executive and senior management positions at various companies, including LabCorp, Exact Sciences, and Quest Diagnostics. Additionally, Hardison has served on the board of directors for several private and public companies.

Dec 07, 2016

Sam Samad

Illumina has appointed Sam Samad as senior vice president and CFO, effective Jan. 6, 2017. Marc Stapley, who had been serving as CFO and chief administrative officer for Illumina, will continue to serve as CAO. Samad joins Illumina from Cardinal Health, where he most recently served as senior vice president and corporate treasurer and was responsible for Cardinal Health's China business. Prior to that role, he was senior vice president and chief financial officer for the pharmaceutical segment and vice president of the healthcare supply chain services. Previously, he held finance roles at Eli Lilly and PepsiCo. 

Pages

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.